NEW YORK (GenomeWeb) – KeyGene announced today that it has licensed its proprietary sequence-based genotyping (SBG) technology to the University of Wisconsin-Madison.

The technology allows for genome-wide SNP discovery and genotyping in large populations of organisms in a single experiment. Under the terms of the deal, UW-Madison will be able to offer SBG services in all species to its research collaborators and clients worldwide. Additional terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.